Parkinson’s disease is the second most common incurable neurodegenerative disorder after Alzheimer’s disease.
It is characterised by the accumulation of protein deposits in dopaminergic neurons (in charge of producing dopamine) in the form of amyloid fibres. These aggregates are formed mainly by the alpha-synuclein protein and in a very complex manner, which makes it complicated to identify molecules which could prevent or revert the process and the neurodegeneration associated with it.
A scientific collaboration led by researchers at the Institute of Biotechnology and Biomedicine (IBB) of the Universitat Autònoma de Barcelona has identified a molecule which halts and reverts this neurodegeneration. After analysing over 14,000 molecules, they found the SynuClean-D molecule, which inhibits the aggregation of the alpha-synuclein protein and breaks the already formed amyloid fibres, thus preventing the initiation of the process causing the onset of the neurodegenerative Parkinson’s disease.
Through experiments conducted with the small Caenorhabditis elegans worm, one of the most commonly used animal models in neurodegenerative diseases, researchers were able to verify that by administering it through food, the molecule was capable of notably reducing alpha-synuclein aggregations, preventing the spread of toxic aggregates and therefore avoiding the degeneration of dopaminergic neurons.
“Everything seems to indicate that the molecule we identified, the SynuClean-D, may provide therapeutic applications for the treatment of neurodegenerative disases such as Parkinson’s in the future”, UAB researcher and coordinator of the study Salvador Ventura points out.
To identify SynuClean-D researchers developed a methodology capable of indentifying the alpha-synuclein aggregation inhibitors among thousands of molecules. Once identified, an in vitro biophysical characterisation was conducted of their inhibiting activity and tests were run to discover their behaviour with human neural cell cultures, before testing it in animal models of the disease (the Caenorhabditis elegans worm). These animals express the alpha-synuclein in the muscle or in dopaminergic neurons. The experiments demonstrated that the administration of the identified inhibitor reduced protein aggregation, improving the mobility of the animal and protecting it from neural degeneration.
The Latest on: Parkinson’s
via Google News
The Latest on: Parkinson’s
- Study Released by Ontario WSIB Must Be Applied to Compensation Across Canada, Say Steelworkerson May 8, 2020 at 12:55 pm
Leaders of the United Steelworkers union (USW) say a study proving the link between Parkinsons disease and the use of McIntyre (aluminum) powder in Ontario mine ...
- Acorda Reports First Quarter 2020 Financial Results and Provides Business Updateon May 5, 2020 at 1:00 pm
Acorda Therapeutics, Inc. (NASDAQ: ACOR) today provided a business update and reported its financial results for the first quarter ended March 31, 2020.
- Parkinsons Disease Treatment Market: Booming Key Players GlaxoSmithKline Plc, Merck KGaA, Novartis AG, Bausch Health, AbbVie Inc.on May 5, 2020 at 4:57 am
Parkinsons disease is one of the progressive nervous system disorder that affects the movement of individuals The symptoms of Parkinsons starts gradually with a barely noticeable tremors in one hand ...
- Ozzy Osbourne Remains In Good Spirits Since Parkinsons Diagnosison May 4, 2020 at 12:25 am
Ozzy Osbourne revealed he had been diagnosed with Parkinson's - which is a brain disorder that leads to shaking, stiffness, and difficulty with walking, balance, and coordination - earlier this year, ...
- Vale David ‘Chook’ Howell: the Cherrypicker who stole Newcastle’s hearton May 1, 2020 at 1:22 pm
Former Young Cherrypicker David “Chook” Howell, achieved an unprecedented seven premiership wins during his career as a league footballer. Photo: Supplied. If there was a man to be feared on the ...
- Tacos to benefit Punchin’ Out Parkinsons of Central Kansason April 30, 2020 at 4:12 pm
Punchin’ Out Parkinsons of Central Kansas will be celebrating Cinco De Mayo on Tuesday by delivering La Curva Tacos during lunch on Tuesday, May 5, ...
- Europe Parkinsons Disease Treatments Market will take the highest jump during 2020-2025on April 30, 2020 at 7:50 am
"Global Parkinsons Disease Treatments Market Overview: The Global Parkinsons Disease Treatments Market report provides a detailed analysis of the dynamic of the market with extensive focus on ...
- 100+ Washington nonprofits that need your support now more than everon April 29, 2020 at 11:47 pm
Dozens of nonprofits around Washington have had to cancel major Spring fundraising events -- and could use your donations.
- Europe Parkinsons Disease Treatments Market will take the highest jump during 2020-2025on April 29, 2020 at 8:50 pm
The Global Parkinsons Disease Treatments Market report provides a detailed analysis of the dynamic of the market with extensive focus on secondary research. The report sheds light on the current ...
via Bing News